Alzheimer s & Dementia · 2025 · 23 citations · 51 references
MedicineNeurologyNeuroscienceDementiaMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseBlood-brain Barrier DysfunctionDementia BiomarkersDementia Risk FactorsInsulin ResistanceNeurodegenerative DiseasesAlzheimer Disease DementiaAlzheimer Disease ProgressionAlzheimer’s Disease Barrier DysfunctionBlood - Brain Barrier TransportBlood-brain Barrier PermeabilityInsulin Resistance AssessmentInsulin Resistance BiomarkersMultivariate Linear Models
INTRODUCTION: Growing evidence suggests a connection between insulin resistance and apolipoprotein E (APOE) genotype in Alzheimer's disease (AD) pathogenesis, but the mechanisms are unclear. We examined effects of insulin resistance and APOE genotype on blood-brain barrier (BBB) integrity in AD. METHODS: BBB integrity was measured in 196 biologically-confirmed non-diabetic patients with AD evaluating CSF/serum albumin ratio, kappa and lambda free light chains (FLCs). Insulin resistance was assessed using triglyceride-glucose index (TyG). The impact of TyG on BBB integrity, and its interaction with APOE genotypes, was analyzed using multivariate models. RESULTS: Sixty-four percent of patients with AD showed altered TyG, with the 21.8% classified as high TyG. TyG subgroups were associated with BBB abnormalities, with similar AD clinical and biomarkers profile. A significant interaction between TyG and APOE ε4/ε4 genotype on BBB permeability was found in multivariate analyses. DISCUSSION: Insulin resistance is a common feature in non-diabetic AD and correlates with altered BBB permeability, interacting synergistically with APOE genotype. HIGHLIGHTS: Insulin resistance and apolipoprotein E (APOE) genotype are well-recognized risk factors for Alzheimer's disease (AD). Insulin resistance shows high prevalence in patients with AD. Insulin resistance is related to damage in blood-brain barrier (BBB) integrity. The association between the triglyceride-glucose (TyG) index and BBB permeability varies in relation to APOE genotype; patients with the APOE ε4/ε4 displayed higher BBB permeability.
51
Guy M. McKhann, David S. Knopman, Howard Chertkow et al. · Alzheimer s & Dementia · 2011 · 18.8K citations · Full text
The Clinical Dementia Rating (CDR)
John C. Morris · Neurology · 1993 · 10K citations
Medicine, Neurology, Psychiatry +12
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text
Luis E. Simental‐Mendía, Martha Rodríguez‐Morán, Fernando Guerrero‐Romero · Metabolic Syndrome and Related Disorders · 2008 · 2.5K citations
Medicine, Endocrinology, Diabetology +15
Fernando Guerrero‐Romero, Luis E. Simental‐Mendía, Manuel González-Ortı́z et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 2.3K citations · Full text
Medicine, Endocrinology, Diabetology +15